The Intermediate Filament Synemin Regulates Non-Homologous End Joining in an ATM-Dependent Manner
Open Access
Abstract
The treatment resistance of cancer cells is a multifaceted process in which DNA repair emerged as a potential therapeutic target. DNA repair is predominantly conducted by nuclear events; yet, how extra-nuclear cues impact the DNA damage response is largely unknown. Here, using a high-throughput RNAi-based screen in three-dimensionally-grown cell cultures of head and neck squamous cell carcinoma (HNSCC), we identified novel focal adhesion proteins controlling DNA repair, including the intermediate filament protein, synemin. We demonstrate that synemin critically regulates the DNA damage response by non-homologous end joining repair. Mechanistically, synemin forms a protein complex with DNA-PKcs through its C-terminal tail domain for determining DNA repair processes upstream of this enzyme in an ATM-dependent manner. Our study discovers a critical function of the intermediate filament protein, synemin in the DNA damage response, fundamentally supporting the concept of cytoarchitectural elements as co-regulators of nuclear events.Keywords
Funding Information
- Horizon 2020 Framework Programme (642623)
- Deutsche Krebshilfe (70112151)
This publication has 50 references indexed in Scilit:
- DNA Repair: Translation to the ClinicClinical Oncology, 2019
- ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage ResponseMolecular Cell, 2017
- Non-homologous DNA end joining and alternative pathways to double-strand break repairNature Reviews Molecular Cell Biology, 2017
- DNA Repair2016
- Chromatin perturbations during the DNA damage response in higher eukaryotesDNA Repair, 2015
- LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cellsCancer Letters, 2015
- Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cellsOncogene, 2015
- Focal adhesion signaling and therapy resistance in cancerSeminars in Cancer Biology, 2015
- Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck CancerJNCI: Journal of the National Cancer Institute, 2015
- Recent Advances in Cancer Therapy Targeting Proteins Involved in DNA Double-Strand Break RepairClinical Cancer Research, 2009